Trends in Non-receipt of Recommended COPD Medication

Overview

Journal ERJ Open Res

Specialty Pulmonary Medicine

Date 2022 Apr 28

PMID 35479295

Authors

Michael Poon

Priscila Pequeno

Shawn D Aaron

Matthew B Stanbrook

Harvey H Wong

Peter Cram

Andrea S Gershon

Affiliations

Soon will be listed here.

Abstract

https://bit.ly/3IhK5Y4.

Citing Articles

Guideline-discordant inhaler regimens after COPD hospitalization: associations with rurality, drive time to care, and fragmented care - a United States cohort study.

Baldomero A, Kunisaki K, Wendt C, Henning-Smith C, Hagedorn H, Bangerter A Lancet Reg Health Am. 2023; 26:100597.

PMID: 37766800 PMC: 10520452. DOI: 10.1016/j.lana.2023.100597.

References

Martinez F, Rabe K, Ferguson G, Wedzicha J, Singh D, Wang C . Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study. Am J Respir Crit Care Med. 2020; 203(5):553-564. PMC: 7924571. DOI: 10.1164/rccm.202006-2618OC. View

Ingebrigtsen T, Marott J, Vestbo J, Hallas J, Nordestgaard B, Dahl M . Characteristics of undertreatment in COPD in the general population. Chest. 2013; 144(6):1811-1818. DOI: 10.1378/chest.13-0453. View

Tavakoli H, Johnson K, FitzGerald J, Sin D, Gershon A, Kendzerska T . Trends in prescriptions and costs of inhaled medications in chronic obstructive pulmonary disease: a 19-year population-based study from Canada. Int J Chron Obstruct Pulmon Dis. 2019; 14:2003-2013. PMC: 6732655. DOI: 10.2147/COPD.S210897. View

James G, Donaldson G, Wedzicha J, Nazareth I . Trends in management and outcomes of COPD patients in primary care, 2000-2009: a retrospective cohort study. NPJ Prim Care Respir Med. 2014; 24:14015. PMC: 4373314. DOI: 10.1038/npjpcrm.2014.15. View

Green M, Natajaran N, ODonnell D, Williamson T, Kotecha J, Khan S . Chronic obstructive pulmonary disease in primary care: an epidemiologic cohort study from the Canadian Primary Care Sentinel Surveillance Network. CMAJ Open. 2015; 3(1):E15-22. PMC: 4382041. DOI: 10.9778/cmajo.20140040. View

Celli B, Anderson J, Cowans N, Crim C, Hartley B, Martinez F . Pharmacotherapy and Lung Function Decline in Patients with Chronic Obstructive Pulmonary Disease. A Systematic Review. Am J Respir Crit Care Med. 2020; 203(6):689-698. PMC: 7958521. DOI: 10.1164/rccm.202005-1854OC. View

Gershon A, Warner L, Cascagnette P, Victor J, To T . Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study. Lancet. 2011; 378(9795):991-6. DOI: 10.1016/S0140-6736(11)60990-2. View

Ingebrigtsen T, Marott J, Nordestgaard B, Lange P, Hallas J, Dahl M . Low use and adherence to maintenance medication in chronic obstructive pulmonary disease in the general population. J Gen Intern Med. 2014; 30(1):51-9. PMC: 4284264. DOI: 10.1007/s11606-014-3029-0. View

Make B, Dutro M, Paulose-Ram R, Marton J, Mapel D . Undertreatment of COPD: a retrospective analysis of US managed care and Medicare patients. Int J Chron Obstruct Pulmon Dis. 2012; 7:1-9. PMC: 3273365. DOI: 10.2147/COPD.S27032. View

10.

Gershon A, Campitelli M, Hwee J, Croxford R, To T, Stanbrook M . Socioeconomic Status, Sex, Age and Access to Medications for COPD in Ontario, Canada. COPD. 2015; 12(6):668-79. DOI: 10.3109/15412555.2015.1020148. View

11.

Gershon A, Wang C, Guan J, Vasilevska-Ristovska J, Cicutto L, To T . Identifying individuals with physcian diagnosed COPD in health administrative databases. COPD. 2009; 6(5):388-94. DOI: 10.1080/15412550903140865. View

12.

Lipson D, Crim C, Criner G, Day N, Dransfield M, Halpin D . Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2020; 201(12):1508-1516. PMC: 7301738. DOI: 10.1164/rccm.201911-2207OC. View

13.

Ghosh S, Anderson W, Putcha N, Han M, Curtis J, Criner G . Alignment of Inhaled Chronic Obstructive Pulmonary Disease Therapies with Published Strategies. Analysis of the Global Initiative for Chronic Obstructive Lung Disease Recommendations in SPIROMICS. Ann Am Thorac Soc. 2018; 16(2):200-208. PMC: 6376942. DOI: 10.1513/AnnalsATS.201804-283OC. View